CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 46 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-22 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −144,266 | $6.15 | $888K | 14,866,018 |
| 2025-10-21 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −109,675 | $6.30 | $691K | 15,010,284 |
| 2025-10-20 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −220,535 | $6.20 | $1.4M | 15,119,959 |
| 2025-10-16 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −12,844 | $6.10 | $78K | 15,340,494 |
| 2025-10-15 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −16,671 | $6.07 | $101K | 15,353,338 |
| 2025-10-10 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −2,300 | $6.08 | $14K | 15,370,009 |
| 2025-10-09 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −249,060 | $6.14 | $1.5M | 15,372,309 |
| 2025-10-08 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −466,242 | $6.05 | $2.8M | 15,621,369 |
| 2025-10-07 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −72,133 | $5.60 | $404K | 16,087,611 |
| 2025-10-06 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −73,955 | $5.69 | $421K | 16,159,744 |
| 2025-10-03 | SVF Endurance (Cayman) Ltd 10% owner | Sale 10b5-1 | −450,342 | $5.56 | $2.5M | 16,233,699 |
| 2025-10-01 | SATO VICKI L Director | Sale 10b5-1 | −22,000 | $5.84 | $128K | 1,232,391 |
| 2025-09-02 | SATO VICKI L Director | Sale 10b5-1 | −22,000 | $4.99 | $110K | 1,254,391 |
| 2025-08-01 | SATO VICKI L Director | Sale 10b5-1 | −22,000 | $4.99 | $110K | 1,276,391 |
| 2025-07-17 | Eisner Mark EVP and Chief Medical Officer | Sale 10b5-1 | −3,586 | $5.47 | $20K | 104,618 |
| 2025-07-15 | Eisner Mark EVP and Chief Medical Officer | Sale 10b5-1 | −6,796 | $5.47 | $37K | 108,204 |
| 2025-07-01 | SATO VICKI L Director | Sale 10b5-1 | −22,000 | $5.10 | $112K | 1,298,391 |
| 2025-06-09 | MORE ROBERT J Director | Other disposition | −14,027 | 40,656 | ||
| 2025-06-09 | MORE ROBERT J Director | Other acquisition | +14,027 | 509,917 | ||
| 2025-06-06 | BISCHOFBERGER NORBERT W Director | Other disposition | −10,667 | 13,333 |
Page 5 of 54 · 1,063 trades